01/11/2021Published by Fondazione Gianni Bonadonna at 01/11/2021Categories Events UncategorizedEarly-stage HER2+ breast cancer, HER2 heterogeneity predicts treatment resistance
25/10/2021Published by Fondazione Gianni Bonadonna at 25/10/2021Categories Events UncategorizedThe mechanisms of early immune escape in colorectal cancer
18/10/2021Published by Fondazione Gianni Bonadonna at 18/10/2021Categories Events UncategorizedA possible ‘guide’ for therapy from cancer-associated fibroblasts
11/10/2021Published by Fondazione Gianni Bonadonna at 11/10/2021Categories Events UncategorizedSpreading knowledge and promoting research, the two Foundation’s main objectives
04/10/2021Published by Fondazione Gianni Bonadonna at 04/10/2021Categories Events UncategorizedMultiple myeloma, encouraging data for an immunotherapy with teclistamab
27/09/2021Published by Fondazione Gianni Bonadonna at 27/09/2021Categories Events UncategorizedCDK7 inhibition, a new strategy discussed during ESMO
24/09/2021Published by Fondazione Gianni Bonadonna at 24/09/2021Categories Events UncategorizedEarly stage breast cancer, news from ESMO
22/09/2021Published by Fondazione Gianni Bonadonna at 22/09/2021Categories Events UncategorizedGreat news from ESMO 2021: results from the most important clinical studies
20/09/2021Published by Fondazione Gianni Bonadonna at 20/09/2021Categories Events UncategorizedA paradigm shift in the treatment of metastatic breast cancer
